Analysis of the Genome of the Escherichia coli O157:H7 2006 Spinach-Associated Outbreak Isolate Indicates Candidate Genes That May Enhance Virulence

ABSTRACT In addition to causing diarrhea, Escherichia coli O157:H7 infection can lead to hemolytic-uremic syndrome (HUS), a severe disease characterized by hemolysis and renal failure. Differences in HUS frequency among E. coli O157:H7 outbreaks have been noted, but our understanding of bacterial factors that promote HUS is incomplete. In 2006, in an outbreak of E. coli O157:H7 caused by consumption of contaminated spinach, there was a notably high frequency of HUS. We sequenced the genome of the strain responsible (TW14359) with the goal of identifying candidate genetic factors that contribute to an enhanced ability to cause HUS. The TW14359 genome contains 70 kb of DNA segments not present in either of the two reference O157:H7 genomes. We identified seven putative virulence determinants, including two putative type III secretion system effector proteins, candidate genes that could result in increased pathogenicity or, alternatively, adaptation to plants, and an intact anaerobic nitric oxide reductase gene, norV. We surveyed 100 O157:H7 isolates for the presence of these putative virulence determinants. A norV deletion was found in over one-half of the strains surveyed and correlated strikingly with the absence of stx1. The other putative virulence factors were found in 8 to 35% of the O157:H7 isolates surveyed, and their presence also correlated with the presence of norV and the absence of stx1, indicating that the presence of norV may serve as a marker of a greater propensity for HUS, similar to the correlation between the absence of stx1 and a propensity for HUS.

[1]  A. Maurelli,et al.  Shigella flexneri type III secretion system effectors OspB and OspF target the nucleus to downregulate the host inflammatory response via interactions with retinoblastoma protein , 2009, Molecular microbiology.

[2]  A. Kalia,et al.  A Dot/Icm‐translocated ankyrin protein of Legionella pneumophila is required for intracellular proliferation within human macrophages and protozoa , 2008, Molecular microbiology.

[3]  A. Goesmann,et al.  Bacteriophage 2851 Is a Prototype Phage for Dissemination of the Shiga Toxin Variant Gene 2c in Escherichia coli O157:H7 , 2008, Infection and Immunity.

[4]  C. Roy,et al.  Ankyrin Repeat Proteins Comprise a Diverse Family of Bacterial Type IV Effectors , 2008, Science.

[5]  David A. D'Argenio,et al.  Large-insert genome analysis technology detects structural variation in Pseudomonas aeruginosa clinical strains from cystic fibrosis patients. , 2008, Genomics.

[6]  T. Whittam,et al.  Variation in virulence among clades of Escherichia coli O157:H7 associated with disease outbreaks , 2008, Proceedings of the National Academy of Sciences.

[7]  A. Torres,et al.  Polysaccharides Cellulose, Poly-β-1,6-N-Acetyl-d-Glucosamine, and Colanic Acid Are Required for Optimal Binding of Escherichia coli O157:H7 Strains to Alfalfa Sprouts and K-12 Strains to Plastic but Not for Binding to Epithelial Cells , 2008, Applied and Environmental Microbiology.

[8]  Rick L. Stevens,et al.  The RAST Server: Rapid Annotations using Subsystems Technology , 2008, BMC Genomics.

[9]  E. Boedeker,et al.  Pathogenesis and treatment of Shiga toxin-producing Escherichia coli infections , 2008, Current opinion in gastroenterology.

[10]  M. Dierich,et al.  The Shiga toxin genotype rather than the amount of Shiga toxin or the cytotoxicity of Shiga toxin in vitro correlates with the appearance of the hemolytic uremic syndrome. , 2007, Diagnostic microbiology and infectious disease.

[11]  B. Morgenstern,et al.  Comparative analysis of the complete genome sequence of the plant growth–promoting bacterium Bacillus amyloliquefaciens FZB42 , 2007, Nature Biotechnology.

[12]  T. Hindré,et al.  Nitric oxide inhibits Shiga-toxin synthesis by enterohemorrhagic Escherichia coli , 2007, Proceedings of the National Academy of Sciences.

[13]  Byron Gallis,et al.  Comparison of Francisella tularensis genomes reveals evolutionary events associated with the emergence of human pathogenic strains , 2007, Genome Biology.

[14]  Christian Weinel,et al.  Population structure of Pseudomonas aeruginosa , 2007, Proceedings of the National Academy of Sciences.

[15]  S. Létoffé,et al.  Heme acquisition by hemophores , 2007, BioMetals.

[16]  S. Payne,et al.  Iron acquisition in Vibrio cholerae , 2007, BioMetals.

[17]  M. Tsai,et al.  Ankyrin repeat: a unique motif mediating protein-protein interactions. , 2006, Biochemistry.

[18]  Regine Hengge,et al.  Cyclic‐di‐GMP‐mediated signalling within the σS network of Escherichia coli , 2006, Molecular microbiology.

[19]  Tetsuya Hayashi,et al.  An extensive repertoire of type III secretion effectors in Escherichia coli O157 and the role of lambdoid phages in their dissemination , 2006, Proceedings of the National Academy of Sciences.

[20]  T. Whittam,et al.  Probing genomic diversity and evolution of Escherichia coli O157 by single nucleotide polymorphisms. , 2006, Genome research.

[21]  E. Murphy,et al.  Iron and Pathogenesis of Shigella: Iron Acquisition in the Intracellular Environment , 2006, Biometals.

[22]  M. Hensel,et al.  The Shiga Toxin 1-Converting Bacteriophage BP-4795 Encodes an NleA-Like Type III Effector Protein , 2005, Journal of bacteriology.

[23]  D. Morse,et al.  Hemolytic Uremic Syndrome Risk and Escherichia coli O157:H7 , 2005, Emerging infectious diseases.

[24]  R. Qiu,et al.  Targeted, haplotype-resolved resequencing of long segments of the human genome. , 2005, Genomics.

[25]  Pierre Legrain,et al.  The Shigella flexneri effector OspG interferes with innate immune responses by targeting ubiquitin-conjugating enzymes. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[26]  David L. Swerdlow,et al.  Epidemiology of Escherichia coli O157:H7 Outbreaks, United States, 1982–2002 , 2005, Emerging infectious diseases.

[27]  Christina Welinder-Olsson,et al.  Enterohemorrhagic Escherichia coli (EHEC) , 2005, Scandinavian journal of infectious diseases.

[28]  A. Friedrich,et al.  Transcriptional Analysis of Genes Encoding Shiga Toxin 2 and Its Variants in Escherichia coli , 2005, Applied and Environmental Microbiology.

[29]  D. Friedman,et al.  The Operator and Early Promoter Region of the Shiga Toxin Type 2-Encoding Bacteriophage 933W and Control of Toxin Expression , 2004, Journal of bacteriology.

[30]  R. Kaul,et al.  Complete Genome Sequence of the Genetically Tractable Hydrogenotrophic Methanogen Methanococcus maripaludis , 2004, Journal of bacteriology.

[31]  C. Solano,et al.  Role of the GGDEF protein family in Salmonella cellulose biosynthesis and biofilm formation , 2004, Molecular microbiology.

[32]  P. Delepelaire,et al.  Bacterial iron sources: from siderophores to hemophores. , 2004, Annual review of microbiology.

[33]  Hung Bui,et al.  A specific genetic background is required for acquisition and expression of virulence factors in Escherichia coli. , 2004, Molecular biology and evolution.

[34]  J. Jofre,et al.  Shiga Toxin 2-Converting Bacteriophages Associated with Clonal Variability in Escherichia coli O157:H7 Strains of Human Origin Isolated from a Single Outbreak , 2003, Infection and Immunity.

[35]  M. Waldor,et al.  Comparison of Shiga Toxin Production by Hemolytic-Uremic Syndrome-Associated and Bovine-Associated Shiga Toxin-Producing Escherichia coli Isolates , 2003, Applied and Environmental Microbiology.

[36]  T. Pysher,et al.  Response to Shiga toxin 1 and 2 in a baboon model of hemolytic uremic syndrome , 2003, Pediatric Nephrology.

[37]  A. Siitonen,et al.  Clinical Escherichia coli Strains Carrying stx Genes: stx Variants and stx-Positive Virulence Profiles , 2002, Journal of Clinical Microbiology.

[38]  P. R. Gardner,et al.  Flavorubredoxin, an Inducible Catalyst for Nitric Oxide Reduction and Detoxification in Escherichia coli * , 2002, The Journal of Biological Chemistry.

[39]  J A Eisen,et al.  The Genome of the Natural Genetic Engineer Agrobacterium tumefaciens C58 , 2001, Science.

[40]  C. Desmarais,et al.  Automated finishing with autofinish. , 2001, Genome research.

[41]  Craig S. Wong,et al.  The risk of the hemolytic-uremic syndrome after antibiotic treatment of Escherichia coli O157:H7 infections. , 2000, The New England journal of medicine.

[42]  K. Meyers,et al.  Many cell types are Shiga toxin targets. , 2000, Kidney international.

[43]  Lukas Wagner,et al.  A Greedy Algorithm for Aligning DNA Sequences , 2000, J. Comput. Biol..

[44]  M. Miyazaki,et al.  Massive outbreak of Escherichia coli O157:H7 infection in schoolchildren in Sakai City, Japan, associated with consumption of white radish sprouts. , 1999, American journal of epidemiology.

[45]  H. Karch,et al.  Epidemiology and diagnosis of Shiga toxin-producing Escherichia coli infections. , 1999, Diagnostic microbiology and infectious disease.

[46]  S. McEwen,et al.  Associations between Virulence Factors of Shiga Toxin-ProducingEscherichia coli and Disease in Humans , 1999, Journal of Clinical Microbiology.

[47]  C. Bloch,et al.  "Black holes" and bacterial pathogenicity: a large genomic deletion that enhances the virulence of Shigella spp. and enteroinvasive Escherichia coli. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[48]  P Green,et al.  Base-calling of automated sequencer traces using phred. II. Error probabilities. , 1998, Genome research.

[49]  P. Green,et al.  Consed: a graphical tool for sequence finishing. , 1998, Genome research.

[50]  P. Green,et al.  Base-calling of automated sequencer traces using phred. I. Accuracy assessment. , 1998, Genome research.

[51]  Thomas L. Madden,et al.  Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. , 1997, Nucleic acids research.

[52]  A. Torres,et al.  Haem iron‐transport system in enterohaemorrhagic Escherichia coli O157:H7 , 1997, Molecular microbiology.

[53]  D. Schwartz,et al.  Optical mapping approaches to molecular genomics. , 1997, Current opinion in biotechnology.

[54]  T. Obrig,et al.  Specific interaction of Escherichia coli O157:H7-derived Shiga-like toxin II with human renal endothelial cells. , 1995, The Journal of infectious diseases.

[55]  J. Samuel,et al.  Comparison of the relative toxicities of Shiga-like toxins type I and type II for mice , 1993, Infection and immunity.

[56]  J. Yu,et al.  A genetic locus of enteropathogenic Escherichia coli necessary for the production of attaching and effacing lesions on tissue culture cells. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[57]  S. Ostroff,et al.  Toxin genotypes and plasmid profiles as determinants of systemic sequelae in Escherichia coli O157:H7 infections. , 1989, The Journal of infectious diseases.

[58]  J. Wells,et al.  Hemorrhagic colitis associated with a rare Escherichia coli serotype. , 1983, The New England journal of medicine.

[59]  Richard H. Price,et al.  Black Holes , 1997 .

[60]  A. Gobert,et al.  Differential expression of stx2 variants in Shiga toxin-producing Escherichia coli belonging to seropathotypes A and C. , 2008, Microbiology.

[61]  M. Hattori,et al.  Complete genome sequence of enterohemorrhagic Escherichia coli O157:H7 and genomic comparison with a laboratory strain K-12. , 2001, DNA research : an international journal for rapid publication of reports on genes and genomes.